The detail
STEP trials used 2.4 mg semaglutide. Doses below 1 mg show diminishing weight loss returns. Microdosing claims often unverified anecdotal. May offer reduced side effects during slight metabolic benefits, but shouldn't expect major weight loss. Not FDA-approved approach.
Sources
Was this helpful?